Drawing for IMITA

USPTO serial 79303441

IMITA

Reviewed by CopyMark Law Group

Reg. 6661834Status 700Registered
Filing date
Status date
Registration date
Mar 8, 2022
Examiner
VAGHANI, MAYUR C
Law office
PETITIONS OFFICE

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMITA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Bone implants comprising living tissue; biological bone implant material comprising living tissue; surgical implants comprised of living tissues; cell therapies, namely, living cells for medical use, stem cells for medical use, endocrine progenitor cells for medical use; pharmaceutical preparations for restoration of endocrine function and metabolic control; pharmaceutical products for restoration of endocrine function and metabolic control; cells for medical use; cells for medical purposes; stem cells for medical purposes; endocrine progenitor cells for medical use; therapeutic medical drugs for restoration of endocrine function and metabolic control; preparations for medical purposes, namely, bone implants incorporating living cells for medical purposesACTIVE—
010Bone implants comprising artificial materials; immuno-protective devices, namely, implants made of artificial materials; implantable medical devices, namely, medical, surgical and orthopaedic implants made of artificial materials; implantable medical devices with an immune-protective function, namely, implants consisting primarily of artificial materials and also including biological materials; implantable devices for the delivery of automatic medication, namely, implants consisting primarily of artificial materials; implantable devices for medical use in measuring the composition of body fluids; medical implants made of artificial materials; orthopaedic implants of artificial materials; artificial implants; medical apparatus and instruments for use in orthopaedic medical procedures; cell culture apparatus for medical use, namely, implantable cell culture chambers; drug delivery apparatus, namely, devices carrying cells for the delivery of drugs, implantable devices carrying cells for the delivery of drugs, cell cargo carriers for the delivery of drugsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 6, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 29, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 8, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 8, 2022FIMPFINAL DISPOSITION PROCESSED—
Jun 8, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2022CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jan 10, 2022APETASSIGNED TO PETITION STAFF—
Dec 22, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 21, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 21, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2021GPNXNOTIFICATION PROCESSED BY IB—
Dec 1, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 1, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 1, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 17, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Nov 17, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 17, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 17, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2021RFNTREFUSAL PROCESSED BY IB—
Apr 19, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 19, 2021RFRRREFUSAL PROCESSED BY MPU—
Apr 14, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2021DOCKASSIGNED TO EXAMINER—
Feb 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance